New Head of Analytics to Help Healthcare Target Interventions for Better Outcomes

MedeAnalyticsA new head of analytics at the UK arm of MedeAnalytics, a pioneer in health analytics, is to help healthcare planners and frontline staff understand which patients, across their entire local population, are at risk of specific adverse events and what interventions will work for individual patients as a means of prevention.

Paul Molyneux, who has held posts at the Care Quality Commission (CQC), Cerner and Dr Foster, has joined a rapidly growing team of world-class specialists at MedeAnalytics in the UK. Working with areas like Hertfordshire, the team has helped health and social care organisations overcome information governance obstacles to create a joined-up health economy. The result is that for the first time, organisations can safely link and unlock their data for use across health and social care whilst still securely maintaining patient privacy.

Molyneux, who was once part of the Healthcare Commission team that uncovered statistical outliers related to the Mid Staffordshire scandal, will now work closely with clinical and epidemiological colleagues at MedeAnalytics and throughout health and care.

He will help to develop risk models that predict which interventions will prove successful for specific patients and that will allow resources to be targeted where they will work across populations.

Commenting on his appointment Molyneux said: "If you can measure something, you can manage it. MedeAnalytics has become the first to solve major governance obstacles to enable the safe sharing and use of information between authorised users across different care settings. I look forward to working with customers throughout the UK to help them unleash the power of that information by predicting where and when, across their health economy, they can have the maximum impact for patients. Crucially, this is about getting research onto the shop floor and into practice, in order to improve outcomes."

Molyneux's new role at MedeAnalytics follows a series of high profile appointments in the UK for the company, including Professor Simon Jones, former chief statistician at Dr Foster, and Dr Mark Davies, the former medical director at the Health and Social Care Information Centre.

Wayne Parslow, UK general manager at MedeAnalytics, said: "Having the right people in place with the right tools to respond to real NHS and healthcare challenges is crucial. Paul will work closely with Professor Jones and Dr Davies to hone new ideas on predictive analytics, with real clinical understanding, so that we can help local health economies deliver services that are truly focussed on achieving the most for individual patients across their population. This will herald a new era of targeted and more efficient health and social care.

"Combining these thought leaders, with the right technology, and working in collaboration with those on the frontline, will allow the NHS and social care to not only understand which patients are at risk, but where, when and how they can successfully intervene."

About MedeAnalytics
MedeAnalytics provides evidence-based insights to solve a real problem that plagues healthcare - how to use the immense amount of patient data collected along the care continuum to deliver cost-effective care and promote a healthier population. Its analytics platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics' cloud-based tools have been used to uncover business insights for nearly 1,000 healthcare organizations across the United States and United Kingdom. The company has also been named one of Modern Healthcare's top 100 Best Places to Work in Healthcare for 2014.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...